MarketCap
Maravai LifeSciences Holdings MRVI
$ 7.73
3.76%
Facebook
X
Telegram
Country |
 USA |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
144 M |
Market Cap[1] |
$ 1.12 B |
EBITDA (LTM) |
$ -192 M |
P/E (LTM) |
-8.133333 |
P/S (LTM) |
5.689125 |
EPS (LTM) |
-0.9 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Annexon
ANNX
|
$ 4.33 | 3.34 % | $ 672 M | Nasdaq Global Select Market | USA |
 |
AbbVie
ABBV
|
$ 294.7 | 3.04 % | $ 521 B | NYSE,SPB | USA |
 |
Amgen
AMGN
|
$ 478.61 | 3.76 % | $ 257 B | Nasdaq Global Select Market,SPB | USA |
 |
Geron Corporation
GERN
|
$ 1.07 | 15.32 % | $ 713 M | Nasdaq Global Select Market | USA |
 |
Theratechnologies
THTX
|
- | - | $ 83.9 M | Nasdaq Capital Market |  Canada |
 |
Aldeyra Therapeutics
ALDX
|
$ 0.65 | 4.82 % | $ 39 M | Nasdaq Global Select Market | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
$ 160.93 | 0.65 % | $ 21.1 B | Nasdaq Global Select Market,SPB | USA |
 |
C4 Therapeutics
CCCC
|
$ 3.12 | -2.96 % | $ 259 M | Nasdaq Global Select Market | USA |
 |
Merck & Co.
MRK
|
$ 150.29 | 3.88 % | $ 376 B | NYSE,SPB | USA |
 |
Cardiff Oncology
CRDF
|
$ 0.87 | 0.78 % | $ 58.2 M | Nasdaq Capital Market | USA |
 |
Evogene Ltd.
EVGN
|
$ 0.36 | -1.36 % | $ 2.83 M | Nasdaq Global Market |  Israel |
 |
Ocugen
OCGN
|
$ 0.87 | 17.34 % | $ 272 M | Nasdaq Capital Market | USA |
 |
Revolution Medicines
RVMD
|
$ 199.48 | 2.7 % | $ 37.9 B | Nasdaq Global Select Market | USA |
 |
Titan Pharmaceuticals
TTNP
|
- | -3.76 % | $ 3.47 M | Nasdaq Capital Market | USA |
 |
BioVie
BIVI
|
$ 1.32 | -23.7 % | $ 1.95 M | Nasdaq Capital Market | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Gossamer Bio
GOSS
|
$ 9.95 | 7.22 % | $ 2.27 B | Nasdaq Global Select Market,SPB | USA |
 |
TCR2 Therapeutics
TCRR
|
- | - | $ 58.1 M | Nasdaq Global Select Market,SPB | USA |
 |
GlaxoSmithKline plc
GSK
|
$ 51.05 | 4.83 % | $ 207 B | NYSE |  Britain |
 |
Crinetics Pharmaceuticals
CRNX
|
$ 84.95 | 0.13 % | $ 7.99 B | Nasdaq Global Select Market | USA |
 |
TFF Pharmaceuticals
TFFP
|
- | -60.05 % | $ 125 K | Nasdaq Global Select Market | USA |
 |
United Therapeutics Corporation
UTHR
|
$ 608.19 | 1.14 % | $ 26.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
- | -15.15 % | $ 60.3 M | Nasdaq Global Select Market | Britain |
 |
AVEO Pharmaceuticals
AVEO
|
- | - | $ 521 M | Nasdaq Capital Market | USA |
 |
InflaRx N.V.
IFRX
|
$ 1.42 | -12.65 % | $ 95.5 M | Nasdaq Global Select Market |  Germany |
 |
Immunome
IMNM
|
$ 19.54 | -3.79 % | $ 1.71 B | Nasdaq Global Select Market | USA |
|
Immatics N.V.
IMTX
|
$ 6.9 | -2.47 % | $ 844 M | Nasdaq Global Select Market | Germany |
 |
Incyte Corporation
INCY
|
$ 122.89 | 4.51 % | $ 24 B | Nasdaq Global Select Market,SPB | USA |
 |
Axcella Health
AXLA
|
- | -16.42 % | $ 249 M | Nasdaq Global Market | USA |
 |
Insmed Incorporated
INSM
|
$ 109.95 | 5.28 % | $ 21.9 B | Nasdaq Global Select Market | USA |
 |
Iovance Biotherapeutics
IOVA
|
$ 8.72 | -1.25 % | $ 3.12 M | Nasdaq Global Market,SPB | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
$ 3.75 | 7.0 % | $ 607 M | Nasdaq Global Select Market | USA |
 |
Jaguar Health
JAGX
|
$ 0.5 | -10.33 % | $ 1.17 M | Nasdaq Capital Market | USA |
 |
Dynavax Technologies Corporation
DVAX
|
- | - | $ 2.02 B | Nasdaq Capital Market | USA |
 |
Viridian Therapeutics
VRDN
|
$ 29.04 | 15.47 % | $ 2.96 B | Nasdaq Capital Market | USA |
 |
Johnson & Johnson
JNJ
|
$ 276.4 | 3.84 % | $ 665 B | NYSE,SPB | USA |
 |
Kala Pharmaceuticals
KALA
|
$ 0.18 | 3.06 % | $ 1.47 M | Nasdaq Global Select Market | USA |
 |
Xencor
XNCR
|
$ 34.95 | 14.07 % | $ 2.59 B | Nasdaq Global Select Market,SPB | USA |
 |
Tyme Technologies
TYME
|
- | 8.07 % | $ 54 M | Nasdaq Capital Market | USA |
 |
Keros Therapeutics
KROS
|
$ 10.89 | 0.55 % | $ 405 M | Nasdaq Global Select Market | USA |
 |
Krystal Biotech
KRYS
|
$ 307.81 | 0.91 % | $ 8.91 B | Nasdaq Global Market,SPB | USA |
 |
Kura Oncology
KURA
|
$ 7.73 | -21.76 % | $ 678 M | Nasdaq Global Select Market | USA |
 |
Kazia Therapeutics Limited
KZIA
|
$ 8.08 | -0.25 % | $ 122 M | Nasdaq Global Select Market |  Australia |
 |
Compugen Ltd.
CGEN
|
$ 2.03 | 1.0 % | $ 190 M | Nasdaq Global Market,SPB | Israel |
 |
Lineage Cell Therapeutics
LCTX
|
$ 1.03 | 1.98 % | $ 237 M | NYSE American | USA |
 |
Cyclerion Therapeutics
CYCN
|
$ 34.99 | 3.77 % | $ 147 M | Nasdaq Global Select Market | USA |
 |
Завод ДИОД
DIOD
|
- | - | - | MOEX,SPB |  Russia |
 |
Eli Lilly and Company
LLY
|
$ 1 421.98 | 0.89 % | $ 1.28 T | NYSE,SPB | USA |
 |
Liquidia Corporation
LQDA
|
$ 47.41 | 12.35 % | $ 4.08 B | Nasdaq Capital Market | USA |
 |
Mustang Bio
MBIO
|
$ 0.42 | 1.98 % | $ 2.06 M | Nasdaq Global Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.